MedPath

Ranbaxy Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Established
1996-08-30
Employees
-
Market Cap
-
Website

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776490
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00776334
Locations
🇺🇸

Gateway Medical Research Inc., St.charles, Missouri, United States

Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
80
Registration Number
NCT00776282

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776139
Locations
🇺🇸

Bioanalytical Systems, Inc., Baltimore, Maryland, United States

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00775996
Locations
🇺🇸

MDS Pharma Services, Lincoln, Nebraska, United States

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00775372
Locations
🇮🇳

Ranbaxy Research Laboratories, Gurgaon, Haryana, India

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00775619

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00776113

Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00775905
Locations
🇺🇸

SFBC Ft. Myers, Inc., Fort Myers,, Florida, United States

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
36
Registration Number
NCT00775580
Locations
🇺🇸

aaiPharma, Inc. -AAI Clinic, Chapell Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath